• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

聚糖云对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白B细胞表位预测的影响

Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.

作者信息

Wintjens René, Bifani Amanda Makha, Bifani Pablo

机构信息

Unit of Microbiology, Bioorganic and Macromolecular Chemistry, Department of Research in Drug Development (RD3), Faculté de Pharmacie, Université Libre de Bruxelles, 1050 Brussels, Belgium.

Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, 169857 Singapore.

出版信息

NPJ Vaccines. 2020 Sep 4;5:81. doi: 10.1038/s41541-020-00237-9. eCollection 2020.

DOI:10.1038/s41541-020-00237-9
PMID:32944295
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7474083/
Abstract

The SARS-CoV-2 outbreak originated in China in late 2019 and has since spread to pandemic proportions. Diagnostics, therapeutics and vaccines are urgently needed. We model the trimeric Spike protein, including flexible loops and all N-glycosylation sites, in order to elucidate accessible epitopes for antibody-based diagnostics, therapeutics and vaccine development. Based on published experimental data, six homogeneous glycosylation patterns and two heterogeneous ones were used for the analysis. The glycan chains alter the accessible surface areas on the S-protein, impeding antibody-antigen recognition. In presence of glycan, epitopes on the S1 subunit, that notably contains the receptor binding domain, remain mostly accessible to antibodies while those present on the S2 subunit are predominantly inaccessible. We identify 28 B-cell epitopes in the Spike structure and group them as non-affected by the glycan cloud versus those which are strongly masked by the glycan cloud, resulting in a list of favourable epitopes as targets for vaccine development, antibody-based therapy and diagnostics.

摘要

严重急性呼吸综合征冠状病毒2(SARS-CoV-2)疫情于2019年末在中国爆发,此后已蔓延至大流行程度。迫切需要诊断方法、治疗方法和疫苗。我们对三聚体刺突蛋白进行建模,包括柔性环和所有N-糖基化位点,以阐明基于抗体的诊断、治疗和疫苗开发中可及的表位。基于已发表的实验数据,使用六种均匀糖基化模式和两种异质糖基化模式进行分析。聚糖链改变了S蛋白上的可及表面积,阻碍了抗体-抗原识别。在存在聚糖的情况下,S1亚基上的表位(该亚基显著包含受体结合域)对抗体大多仍可及,而S2亚基上的表位则主要不可及。我们在刺突结构中鉴定出28个B细胞表位,并将它们分为不受聚糖云影响的表位和被聚糖云强烈掩盖的表位,从而得出一系列有利的表位作为疫苗开发、基于抗体的治疗和诊断的靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/4d81ff23114d/41541_2020_237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/aea60998523b/41541_2020_237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/58b976406a1f/41541_2020_237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/f2c76240dc08/41541_2020_237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/4d81ff23114d/41541_2020_237_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/aea60998523b/41541_2020_237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/58b976406a1f/41541_2020_237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/f2c76240dc08/41541_2020_237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76a/7474083/4d81ff23114d/41541_2020_237_Fig4_HTML.jpg

相似文献

1
Impact of glycan cloud on the B-cell epitope prediction of SARS-CoV-2 Spike protein.聚糖云对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白B细胞表位预测的影响
NPJ Vaccines. 2020 Sep 4;5:81. doi: 10.1038/s41541-020-00237-9. eCollection 2020.
2
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.全面描述了针对 SARS-CoV-2 刺突蛋白的抗体反应,发现了除轻度感染诱导的表位之外的其他疫苗诱导的表位。
Elife. 2022 Jan 24;11:e73490. doi: 10.7554/eLife.73490.
3
A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.一种糖基化 RBD 蛋白诱导针对奥密克戎和其他变体的增强型中和抗体,提高对 SARS-CoV-2 感染的保护作用。
J Virol. 2022 Sep 14;96(17):e0011822. doi: 10.1128/jvi.00118-22. Epub 2022 Aug 16.
4
Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern.新型针对 SARS-CoV-2 关切变异株的 S2 亚单位特异性抗体,具有广泛的中和活性。
Front Immunol. 2023 Dec 8;14:1307693. doi: 10.3389/fimmu.2023.1307693. eCollection 2023.
5
Inducing enhanced neutralizing antibodies against broad SARS-CoV-2 variants through glycan-shielding multiple non-neutralizing epitopes of RBD.通过糖基掩蔽 RBD 的多个非中和表位诱导针对广泛 SARS-CoV-2 变体的增强型中和抗体。
Front Immunol. 2023 Dec 11;14:1259386. doi: 10.3389/fimmu.2023.1259386. eCollection 2023.
6
Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants.糖基化掩盖棘突蛋白 NTD 和 RBD 表位可诱导针对 SARS-CoV-2 变体的广泛中和抗体。
Front Immunol. 2021 Dec 2;12:795741. doi: 10.3389/fimmu.2021.795741. eCollection 2021.
7
Discordant Antigenic Properties of Soluble and Virion SARS-CoV-2 Spike Proteins.可溶性和病毒 SARS-CoV-2 刺突蛋白的抗原性差异。
Viruses. 2024 Mar 6;16(3):407. doi: 10.3390/v16030407.
8
Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.SARS-CoV-2 刺突蛋白细胞表位和糖基化特征在 COVID-19 全球传播过程中的变化。
Front Immunol. 2020 Sep 4;11:565278. doi: 10.3389/fimmu.2020.565278. eCollection 2020.
9
Characterization of a neutralizing antibody that recognizes a loop region adjacent to the receptor-binding interface of the SARS-CoV-2 spike receptor-binding domain.鉴定一种中和抗体,该抗体识别 SARS-CoV-2 刺突受体结合结构域紧邻受体结合界面的环区。
Microbiol Spectr. 2024 Apr 2;12(4):e0365523. doi: 10.1128/spectrum.03655-23. Epub 2024 Feb 28.
10
A glycan cluster on the SARS-CoV-2 spike ectodomain is recognized by Fab-dimerized glycan-reactive antibodies.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白胞外结构域上的聚糖簇可被Fab二聚化的聚糖反应性抗体识别。
bioRxiv. 2020 Jun 30:2020.06.30.178897. doi: 10.1101/2020.06.30.178897.

引用本文的文献

1
Non-Glycosylated SARS-CoV-2 Omicron BA.5 Receptor Binding Domain (RBD) with a Native-like Conformation Induces a Robust Immune Response with Potent Neutralization in a Mouse Model.具有天然构象的非糖基化 SARS-CoV-2 奥密克戎 BA.5 受体结合域(RBD)在小鼠模型中引发强烈免疫应答并具有强大的中和作用。
Molecules. 2024 Jun 5;29(11):2676. doi: 10.3390/molecules29112676.
2
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development.SARS-CoV-2 刺突蛋白的免疫表位及通用疫苗开发的考虑因素。
Immunohorizons. 2024 Mar 1;8(3):214-226. doi: 10.4049/immunohorizons.2400003.
3
Stabilization of the Metastable Pre-Fusion Conformation of the SARS-CoV-2 Spike Glycoprotein through N-Linked Glycosylation of the S2 Subunit.

本文引用的文献

1
Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins.针对重组 SARS-CoV-2 刺突蛋白的位点特异性 N-糖基化分析。
Mol Cell Proteomics. 2021;20:100058. doi: 10.1074/mcp.RA120.002295. Epub 2021 Feb 11.
2
A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.一种 SARS-CoV-2 疫苗候选物可能与所有当前流行的变异株相匹配。
Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23652-23662. doi: 10.1073/pnas.2008281117. Epub 2020 Aug 31.
3
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits.
通过 S2 亚基的 N-连接糖基化稳定 SARS-CoV-2 刺突糖蛋白的亚稳定预融合构象。
Viruses. 2024 Jan 31;16(2):223. doi: 10.3390/v16020223.
4
Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies.酿酒位:公共卫生突发事件期间用于精炼 B 细胞表位预测的流水线。
Front Immunol. 2023 Dec 6;14:1278534. doi: 10.3389/fimmu.2023.1278534. eCollection 2023.
5
Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development.严重急性呼吸综合征冠状病毒2刺突蛋白的免疫表位与通用疫苗研发的考量
bioRxiv. 2023 Oct 27:2023.10.26.564184. doi: 10.1101/2023.10.26.564184.
6
A bioengineered pseudovirus nanoparticle displaying SARS-CoV 2 RBD fully protects mice from mortality and weight loss caused by SARS-CoV 2 challenge.一种展示 SARS-CoV-2 RBD 的生物工程假病毒纳米颗粒可完全保护小鼠免受 SARS-CoV-2 攻击引起的死亡率和体重减轻。
Biotechnol J. 2023 Oct;18(10):e2300130. doi: 10.1002/biot.202300130. Epub 2023 Jun 23.
7
35B5 antibody potently neutralizes SARS-CoV-2 Omicron by disrupting the N-glycan switch via a conserved spike epitope.35B5 抗体通过破坏保守的刺突表位上的 N-糖基化开关,有力地中和了 SARS-CoV-2 奥密克戎。
Cell Host Microbe. 2022 Jun 8;30(6):887-895.e4. doi: 10.1016/j.chom.2022.03.035. Epub 2022 Mar 29.
8
Sagacious epitope selection for vaccines, and both antibody-based therapeutics and diagnostics: tips from virology and oncology.用于疫苗、基于抗体的治疗药物和诊断方法的明智表位选择:来自病毒学和肿瘤学的提示
Antib Ther. 2022 Feb 21;5(1):63-72. doi: 10.1093/abt/tbac005. eCollection 2022 Jan.
9
Analysis of the Neutralizing Activity of Antibodies Targeting Open or Closed SARS-CoV-2 Spike Protein Conformations.分析针对开放或闭合 SARS-CoV-2 刺突蛋白构象的抗体的中和活性。
Int J Mol Sci. 2022 Feb 14;23(4):2078. doi: 10.3390/ijms23042078.
10
Synthetic virions reveal fatty acid-coupled adaptive immunogenicity of SARS-CoV-2 spike glycoprotein.合成病毒粒子揭示了 SARS-CoV-2 刺突糖蛋白的脂肪酸偶联适应性免疫原性。
Nat Commun. 2022 Feb 14;13(1):868. doi: 10.1038/s41467-022-28446-x.
兔源 SARS-CoV-2 刺突蛋白免疫原诱导的抗体特征。
Sci Transl Med. 2020 Jul 1;12(550). doi: 10.1126/scitranslmed.abc3539. Epub 2020 Jun 8.
4
Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.COVID-19 患者体内诱导中和抗体的 SARS-CoV-2 刺突蛋白上的两个线性表位。
Nat Commun. 2020 Jun 1;11(1):2806. doi: 10.1038/s41467-020-16638-2.
5
Understanding the B and T cell epitopes of spike protein of severe acute respiratory syndrome coronavirus-2: A computational way to predict the immunogens.解析严重急性呼吸综合征冠状病毒 2 刺突蛋白的 B 和 T 细胞表位:一种预测免疫原的计算方法。
Infect Genet Evol. 2020 Oct;84:104382. doi: 10.1016/j.meegid.2020.104382. Epub 2020 May 27.
6
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.COVID-19 疾病患者和未接触者体内针对 SARS-CoV-2 冠状病毒的 T 细胞反应的靶标。
Cell. 2020 Jun 25;181(7):1489-1501.e15. doi: 10.1016/j.cell.2020.05.015. Epub 2020 May 20.
7
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells.高通量单细胞测序鉴定恢复期患者 B 细胞中的 SARS-CoV-2 强效中和抗体。
Cell. 2020 Jul 9;182(1):73-84.e16. doi: 10.1016/j.cell.2020.05.025. Epub 2020 May 18.
8
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.人类单克隆 SARS-CoV 抗体对 SARS-CoV-2 的交叉中和作用。
Nature. 2020 Jul;583(7815):290-295. doi: 10.1038/s41586-020-2349-y. Epub 2020 May 18.
9
Site-specific glycan analysis of the SARS-CoV-2 spike.新冠病毒刺突蛋白的糖基化位点特异性分析。
Science. 2020 Jul 17;369(6501):330-333. doi: 10.1126/science.abb9983. Epub 2020 May 4.
10
Deducing the N- and O-glycosylation profile of the spike protein of novel coronavirus SARS-CoV-2.推断新型冠状病毒 SARS-CoV-2 刺突蛋白的 N-和 O-糖基化谱。
Glycobiology. 2020 Dec 9;30(12):981-988. doi: 10.1093/glycob/cwaa042.